Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary biliary cirrhosis: historical perspective.

E Jenny Heathcote1

  • 1University of Toronto, Toronto, ON, #170 6B Fell, Toronto Western Hospital, 399 Bathurst St. Toronto, ON M5T 2S8, Canada. jenny.heathcote@utoronto.ca

Clinics in Liver Disease
|November 5, 2003
PubMed
Summary

Primary biliary cholangitis (PBC) is an autoimmune liver disease with unknown causes. Research highlights the need to identify PBC

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.

Journal of hepatology·2017
Same author

Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis.

Clinical journal of gastroenterology·2015
Same author

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.

Hepatology international·2015
Same author

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.

Journal of hepatology·2014
Same author

Impact of a formal mentoring program on academic promotion of Department of Medicine faculty: a comparative study.

Medical teacher·2014
Same author

Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.

Hepatology (Baltimore, Md.)·2013

Area of Science:

  • Hepatology
  • Immunology
  • Epidemiology

Background:

  • Primary biliary cholangitis (PBC) is a chronic liver disease with a long history.
  • Its predilection for women and association with autoimmune conditions suggest immune involvement.
  • Epidemiological data points to the interplay of genetic and environmental factors in PBC pathogenesis.

Observation:

  • The antimitochondrial antibody (AMA) is the most sensitive and specific serologic marker for PBC, identified in 1965.
  • Historically, PBC was fatal; however, over 60% of current diagnoses are asymptomatic.
  • Less than half of diagnosed individuals with PBC succumb to liver disease.

Findings:

  • While the immune system is implicated, the precise etiology of PBC remains elusive.
  • Genetic predisposition and environmental triggers are recognized as significant contributors.
  • The discovery of AMA provided a crucial diagnostic hallmark.

Implications:

  • Despite advances in diagnosis and prognosis, effective therapies to halt or reverse PBC progression are lacking.
  • Further investigation into the etiological factors of PBC is critical for therapeutic development.
  • Understanding the multifactorial nature of PBC is key to advancing patient care.

Related Experiment Videos